Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 26 | 2025 | 1452 | 3.920 |
Why?
|
| Brain Mapping | 15 | 2022 | 132 | 2.160 |
Why?
|
| Magnetic Resonance Imaging | 21 | 2025 | 577 | 1.780 |
Why?
|
| Tobacco Use Disorder | 7 | 2020 | 249 | 1.700 |
Why?
|
| Nicotine | 7 | 2022 | 290 | 1.550 |
Why?
|
| Neural Pathways | 4 | 2018 | 139 | 1.520 |
Why?
|
| Reward | 7 | 2022 | 106 | 1.460 |
Why?
|
| Cannabis | 4 | 2023 | 90 | 1.430 |
Why?
|
| Substance-Related Disorders | 5 | 2023 | 825 | 1.220 |
Why?
|
| Amygdala | 7 | 2022 | 125 | 1.210 |
Why?
|
| Decision Making | 2 | 2022 | 242 | 1.160 |
Why?
|
| Cerebral Cortex | 6 | 2022 | 303 | 1.100 |
Why?
|
| Risk-Taking | 2 | 2022 | 456 | 1.090 |
Why?
|
| Smoking | 8 | 2020 | 1019 | 1.040 |
Why?
|
| Nicotinic Agonists | 5 | 2015 | 87 | 1.020 |
Why?
|
| Cognition | 6 | 2021 | 458 | 0.950 |
Why?
|
| Receptors, Nicotinic | 3 | 2017 | 114 | 0.900 |
Why?
|
| Humans | 57 | 2025 | 42163 | 0.890 |
Why?
|
| Cluster Analysis | 4 | 2020 | 206 | 0.810 |
Why?
|
| Cues | 2 | 2021 | 75 | 0.780 |
Why?
|
| Adolescent | 22 | 2025 | 5950 | 0.770 |
Why?
|
| Child Abuse | 1 | 2023 | 90 | 0.730 |
Why?
|
| Male | 35 | 2025 | 22779 | 0.710 |
Why?
|
| Disease Management | 1 | 2021 | 68 | 0.680 |
Why?
|
| Female | 34 | 2025 | 24018 | 0.670 |
Why?
|
| Substance Withdrawal Syndrome | 4 | 2017 | 126 | 0.660 |
Why?
|
| Prefrontal Cortex | 4 | 2021 | 160 | 0.650 |
Why?
|
| Behavior | 1 | 2020 | 34 | 0.650 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 93 | 0.650 |
Why?
|
| Models, Neurological | 2 | 2018 | 135 | 0.640 |
Why?
|
| Habenula | 1 | 2019 | 4 | 0.640 |
Why?
|
| Medication Adherence | 1 | 2021 | 177 | 0.620 |
Why?
|
| Executive Function | 3 | 2019 | 55 | 0.590 |
Why?
|
| Smoking Cessation | 5 | 2020 | 583 | 0.590 |
Why?
|
| Somatosensory Cortex | 4 | 2006 | 24 | 0.580 |
Why?
|
| Corpus Striatum | 1 | 2019 | 119 | 0.570 |
Why?
|
| Electroencephalography | 4 | 2006 | 135 | 0.560 |
Why?
|
| Evoked Potentials, Somatosensory | 3 | 2006 | 9 | 0.530 |
Why?
|
| HIV Infections | 2 | 2021 | 2535 | 0.530 |
Why?
|
| Quinoxalines | 2 | 2013 | 17 | 0.500 |
Why?
|
| Conduct Disorder | 3 | 2021 | 54 | 0.490 |
Why?
|
| Benzazepines | 2 | 2013 | 33 | 0.490 |
Why?
|
| Rest | 2 | 2013 | 33 | 0.470 |
Why?
|
| Adolescent Development | 3 | 2021 | 39 | 0.460 |
Why?
|
| Adult | 17 | 2024 | 13458 | 0.440 |
Why?
|
| Affective Symptoms | 2 | 2022 | 60 | 0.420 |
Why?
|
| Emotions | 6 | 2022 | 251 | 0.380 |
Why?
|
| Young Adult | 9 | 2022 | 4936 | 0.370 |
Why?
|
| Gyrus Cinguli | 4 | 2021 | 30 | 0.370 |
Why?
|
| Task Performance and Analysis | 3 | 2021 | 47 | 0.360 |
Why?
|
| Child | 10 | 2025 | 3381 | 0.340 |
Why?
|
| Median Nerve | 3 | 2006 | 5 | 0.330 |
Why?
|
| Memory, Short-Term | 1 | 2010 | 56 | 0.330 |
Why?
|
| Cyclonic Storms | 2 | 2021 | 75 | 0.320 |
Why?
|
| Attention | 3 | 2021 | 165 | 0.320 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2019 | 170 | 0.310 |
Why?
|
| Marijuana Smoking | 2 | 2023 | 90 | 0.310 |
Why?
|
| Electric Stimulation | 2 | 2006 | 198 | 0.310 |
Why?
|
| Functional Laterality | 2 | 2006 | 89 | 0.260 |
Why?
|
| Quality of Life | 2 | 2022 | 599 | 0.260 |
Why?
|
| Touch | 1 | 2006 | 19 | 0.250 |
Why?
|
| Neural Inhibition | 1 | 2006 | 48 | 0.250 |
Why?
|
| Hand | 1 | 2006 | 33 | 0.250 |
Why?
|
| Double-Blind Method | 4 | 2017 | 305 | 0.250 |
Why?
|
| Algorithms | 3 | 2005 | 508 | 0.250 |
Why?
|
| Data Interpretation, Statistical | 2 | 2005 | 126 | 0.240 |
Why?
|
| Anxiety | 2 | 2023 | 847 | 0.240 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2022 | 547 | 0.230 |
Why?
|
| Middle Aged | 8 | 2019 | 11819 | 0.230 |
Why?
|
| Social Behavior | 1 | 2025 | 160 | 0.210 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2021 | 55 | 0.210 |
Why?
|
| Social Isolation | 1 | 2023 | 34 | 0.200 |
Why?
|
| Parenting | 1 | 2024 | 135 | 0.200 |
Why?
|
| Acculturation | 1 | 2024 | 203 | 0.190 |
Why?
|
| Motivation | 2 | 2017 | 492 | 0.190 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2025 | 297 | 0.180 |
Why?
|
| Mass Media | 1 | 2021 | 38 | 0.180 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 47 | 0.180 |
Why?
|
| Sexual Maturation | 1 | 2021 | 24 | 0.170 |
Why?
|
| Awareness | 1 | 2021 | 73 | 0.170 |
Why?
|
| Puberty | 1 | 2021 | 31 | 0.170 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 53 | 0.170 |
Why?
|
| Neuropsychological Tests | 1 | 2021 | 281 | 0.160 |
Why?
|
| Likelihood Functions | 2 | 2022 | 62 | 0.160 |
Why?
|
| Child Development | 1 | 2021 | 95 | 0.160 |
Why?
|
| Data Mining | 2 | 2017 | 30 | 0.160 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 319 | 0.160 |
Why?
|
| Placebo Effect | 1 | 2019 | 14 | 0.160 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 32 | 0.160 |
Why?
|
| Disasters | 1 | 2020 | 74 | 0.160 |
Why?
|
| Cross-Over Studies | 3 | 2017 | 112 | 0.160 |
Why?
|
| Students | 2 | 2023 | 617 | 0.150 |
Why?
|
| Pilot Projects | 1 | 2022 | 733 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 379 | 0.150 |
Why?
|
| Multilingualism | 1 | 2019 | 50 | 0.140 |
Why?
|
| Problem Solving | 1 | 2018 | 38 | 0.140 |
Why?
|
| Cannabinoids | 1 | 2019 | 67 | 0.140 |
Why?
|
| Mental Health | 1 | 2022 | 363 | 0.140 |
Why?
|
| Parents | 1 | 2021 | 359 | 0.130 |
Why?
|
| Limbic System | 1 | 2017 | 31 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2021 | 1574 | 0.130 |
Why?
|
| Nerve Net | 2 | 2015 | 96 | 0.120 |
Why?
|
| Case-Control Studies | 3 | 2015 | 1266 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3077 | 0.120 |
Why?
|
| Cerebrum | 1 | 2015 | 2 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2017 | 336 | 0.120 |
Why?
|
| Mental Processes | 1 | 2015 | 16 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 1058 | 0.120 |
Why?
|
| Depression | 1 | 2022 | 837 | 0.120 |
Why?
|
| Cerebellum | 1 | 2015 | 78 | 0.110 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2019 | 67 | 0.110 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 93 | 0.110 |
Why?
|
| Personality | 1 | 2013 | 55 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2016 | 541 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2013 | 452 | 0.090 |
Why?
|
| Placebos | 1 | 2010 | 41 | 0.080 |
Why?
|
| Administration, Cutaneous | 1 | 2010 | 48 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2020 | 18 | 0.080 |
Why?
|
| Physical Stimulation | 2 | 2006 | 27 | 0.080 |
Why?
|
| Psychomotor Performance | 1 | 2010 | 156 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2022 | 1020 | 0.070 |
Why?
|
| Hippocampus | 2 | 2021 | 591 | 0.070 |
Why?
|
| Alcohol Drinking | 2 | 2023 | 585 | 0.070 |
Why?
|
| Impulsive Behavior | 2 | 2017 | 54 | 0.060 |
Why?
|
| Evoked Potentials | 1 | 2005 | 90 | 0.060 |
Why?
|
| Reaction Time | 2 | 2015 | 151 | 0.050 |
Why?
|
| Physics | 1 | 2023 | 2 | 0.050 |
Why?
|
| Parent-Child Relations | 1 | 2024 | 125 | 0.050 |
Why?
|
| Risk Factors | 2 | 2021 | 3942 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2022 | 24 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2024 | 211 | 0.050 |
Why?
|
| Time Factors | 1 | 2006 | 1848 | 0.050 |
Why?
|
| Temperament | 1 | 2021 | 36 | 0.050 |
Why?
|
| Intention | 1 | 2022 | 103 | 0.040 |
Why?
|
| Peer Group | 1 | 2023 | 173 | 0.040 |
Why?
|
| Empathy | 1 | 2021 | 31 | 0.040 |
Why?
|
| Dehydroepiandrosterone | 1 | 2021 | 11 | 0.040 |
Why?
|
| Lebanon | 1 | 2020 | 20 | 0.040 |
Why?
|
| Ethanol | 1 | 2023 | 221 | 0.040 |
Why?
|
| Perception | 1 | 2022 | 209 | 0.040 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 37 | 0.040 |
Why?
|
| Florida | 1 | 2021 | 461 | 0.040 |
Why?
|
| United States | 2 | 2022 | 5072 | 0.040 |
Why?
|
| Testosterone | 1 | 2021 | 211 | 0.040 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 99 | 0.040 |
Why?
|
| Intelligence | 1 | 2019 | 14 | 0.040 |
Why?
|
| Universities | 1 | 2023 | 539 | 0.040 |
Why?
|
| Vocabulary | 1 | 2019 | 19 | 0.040 |
Why?
|
| Individuality | 1 | 2019 | 53 | 0.040 |
Why?
|
| Estradiol | 1 | 2021 | 269 | 0.040 |
Why?
|
| Schools | 1 | 2020 | 283 | 0.040 |
Why?
|
| Adolescent Behavior | 1 | 2020 | 270 | 0.030 |
Why?
|
| Reversal Learning | 1 | 2017 | 4 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 1597 | 0.030 |
Why?
|
| Social Class | 1 | 2019 | 286 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 245 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 1221 | 0.030 |
Why?
|
| Facial Expression | 1 | 2015 | 24 | 0.030 |
Why?
|
| Mental Recall | 1 | 2015 | 81 | 0.030 |
Why?
|
| Oxygen | 1 | 2015 | 217 | 0.030 |
Why?
|
| Research Design | 1 | 2015 | 370 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 87 | 0.010 |
Why?
|
| Artifacts | 1 | 2005 | 23 | 0.010 |
Why?
|